Evidence map›Paper›PMID 38327870›Full record

ArticleNAR genomics and bioinformatics2024

SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model.

Andrew Vargas Palacios, Pujan Acharya, Anthony Stephen Peidl, Moriah Rene Beck, Eduardo Blanco, Avdesh Mishra, Tasneem Bawa-Khalfe, Subash Chandra Pakhrin

Open access · goldAbstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. A Landscape Analysis of Human SUMOylation.Molecular & cellular proteomics : MCP · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Andrew Vargas PalaciosDepartment of Computer Science and Engineering Technology, University of Houston-Downtown, 1 Main St., Houston, TX 77002, USA.
Pujan AcharyaDepartment of Computer Science and Engineering Technology, University of Houston-Downtown, 1 Main St., Houston, TX 77002, USA.
Anthony Stephen PeidlDepartment of Biology and Biochemistry, Center for Nuclear Receptors & Cell Signaling, University of Houston, Houston, TX 77204, USA.
Moriah Rene BeckDepartment of Chemistry and Biochemistry, Wichita State University, 1845 Fairmount St., Wichita, KS 67260, USA.
Eduardo BlancoDepartment of Computer Science, University of Arizona, 1040 4th St., Tucson, AZ 85721, USA.
Avdesh MishraDepartment of Electrical Engineering and Computer Science, Texas A&M University-Kingsville, Kingsville, TX 78363, USA.
Tasneem Bawa-KhalfeDepartment of Biology and Biochemistry, Center for Nuclear Receptors & Cell Signaling, University of Houston, Houston, TX 77204, USA.
Subash Chandra PakhrinDepartment of Computer Science and Engineering Technology, University of Houston-Downtown, 1 Main St., Houston, TX 77002, USA.ORCID https://orcid.org/0009-0009-3310-2939
University of Houston - Downtown · USUniversity of Houston · USTexas A&M University – Kingsville · USUniversity of Arizona · USWichita State University · US

Funding

Targeting Constitutively Active SUMO Modified Androgen Receptors in Endocrine Resistant Breast CancerR01CA256543 · NCI · UNIVERSITY OF HOUSTON · PI BAWA-KHALFE, TASNEEM · 2021 to 2025
$1.8M
NCI NIH HHS R01 CA256543
6 · The paper itself

Abstract

SUMOylation is an essential post-translational modification system with the ability to regulate nearly all aspects of cellular physiology. Three major paralogues SUMO1, SUMO2 and SUMO3 form a covalent bond between the small ubiquitin-like modifier with lysine residues at consensus sites in protein substrates. Biochemical studies continue to identify unique biological functions for protein targets conjugated to SUMO1 versus the highly homologous SUMO2 and SUMO3 paralogues. Yet, the field has failed to harness contemporary AI approaches including pre-trained protein language models to fully expand and/or recognize the SUMOylated proteome. Herein, we present a novel, deep learning-based approach called SumoPred-PLM for human SUMOylation prediction with sensitivity, specificity, Matthew's correlation coefficient, and accuracy of 74.64%, 73.36%, 0.48% and 74.00%, respectively, on the CPLM 4.0 independent test dataset. In addition, this novel platform uses contextualized embeddings obtained from a pre-trained protein language model, ProtT5-XL-UniRef50 to identify SUMO2/3-specific conjugation sites. The results demonstrate that SumoPred-PLM is a powerful and unique computational tool to predict SUMOylation sites in proteins and accelerate discovery.

Identifiers

PMID38327870
PMCPMC10849187
OpenAlexW4391592452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.